(Q37197054)

English

Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial

scientific article published on December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

anti-retroviral agent

0 references

randomized controlled trial

1 reference

based on heuristic

inferred from title

Frederick L Altice

5

object named as

Frederick L Altice

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Duncan Smith-Rohrberg Maru

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Michael J Kozal

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

R Douglas Bruce

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sandra A Springer

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

1 December 2007

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Journal of Acquired Immune Deficiency Syndromes

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

46

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

555-563

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

Rationale and uses of a public HIV drug-resistance database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

A randomised trial comparing genotypic and virtual phenotypic interpretation of HIV drug resistance: the CREST study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

Paradoxes of adherence and drug resistance to HIV antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

A modified poisson regression approach to prospective studies with binary data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

Doubts about DOT: antiretroviral therapy for resource-poor countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

Evaluating supervised HAART in late-stage HIV among drug users: a preliminary report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

Attaining higher goals in HIV treatment: the central importance of adherence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

6 September 2017

Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

14 September 2017

High levels of adherence do not prevent accumulation of HIV drug resistance mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

14 September 2017

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

14 September 2017

Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

14 September 2017

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

14 September 2017

Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

14 September 2017

Assessing Resistance Costs of Antiretroviral Therapies via Measures of Future Drug Options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

14 September 2017

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

26 June 2018

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

26 June 2018

Update of the drug resistance mutations in HIV-1: Fall 2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Directly observed therapy for the management of HIV-infected patients in a methadone program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Efficacy of directly observed treatment of HIV infection: experience in AIDS welfare homes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

Barriers to use of free antiretroviral therapy in injection drug users.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

3 September 2018

The use of community-based modified directly observed therapy for the treatment of HIV-infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

20 October 2018

A Simple, Dynamic Measure of Antiretroviral Therapy Adherence Predicts Failure to Maintain HIV‐1 Suppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

4 December 2018

Predictors and Consequences of Negative Physician Attitudes Toward HIV-Infected Injection Drug Users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684061

4 December 2018

HIV Drug Resistance and HIV Transmission Risk Behaviors Among Active Injection Drug Users

1 reference

https://pubmed.ncbi.nlm.nih.gov/18193497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Access to antiretroviral therapy in HIV-infected injection drug users

1 reference

https://pubmed.ncbi.nlm.nih.gov/18193497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users

1 reference

https://pubmed.ncbi.nlm.nih.gov/18193497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18193497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, controlled trials of directly administered antiretroviral therapy for HIV-infected patients: questions about study population and analytical approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/18193497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Directly observed therapy for HIV antiretroviral therapy in an urban US setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/18193497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/18193497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual Analog Scale of ART Adherence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18193497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18193497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/QAI.0B013E318158C0BD

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37197054&oldid=2130725732"